MarketMindset Posted - 1 week ago

Earnings AH to watch tomorrow: $TTEK $ALVO $DLO $BV $SONO

PenkeTrading Posted - 10/26/24

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Alvotech. Is that bullish or bearish? $ALVO #Alvotech #RsiOverbought #NASDAQ

pcguy2 Posted - 1 month ago

$ALVO shockingly undervalued company. Sales guided 2x in 2025

Bornjever Posted - 1 month ago

$ALVO this European company diversifies our portfolio and has billions in funding with EU big dogs in billions but most encouraging big dogs purchased 850 million shares additional shares and sold only 1,300 shares so far this month. This indicates facts more bio equals have been approved so more sales and profits almost assured.

WeeklyTrader Posted - 1 month ago

Prepare for turbulence with $ALVO! RSI: 58.17% 50-day MA: $11.79 200-day MA: $13.14

briefingcom Posted - 1 month ago

$ALVO: Alvotech and Teva ($TEVA) announce U.S. FDA approval of additional presentation of SELARSDI (ustekinumab-aekn), expanding its label to include further indications approved for reference product, Stelara (ustekinumab) https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241022070643ALVO&utm_campaign=inplay&utm_medium=social&utm_source=&utm_content=view_page

WeeklyTrader Posted - 1 month ago

Who's ready to ride the $ALVO train? RSI: 62.19% 50-day MA: $11.62 200-day MA: $13.12

themacromindset Posted - 1 month ago

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® $ALVO

Stock_Titan Posted - 09/25/24

$ALVO Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio® https://www.stocktitan.net/news/ALVO/alvotech-initiates-confirmatory-patient-study-for-avt16-a-proposed-p588hxupl5gd.html

Fullratio Posted - 2 months ago

Healthcare sector stocks with high gross profit growth in Q2 2024 (TTM): $ADAP $ALVO $GLUE

DonCorleone77 Posted - 3 months ago

$ALVO I do not know the background. You will have to do your own DD: Alvotech files to sell 1.79M ordinary shares for holders The company will not receive any proceeds from the sale of the ordinary shares by the selling shareholder.

Bornjever Posted - 3 months ago

$ALVO best earnings ever and three months from now much better as they have a bunch of approvals in hand and more to be approved in pipeline and very

Fullratio Posted - 3 months ago

$ALVO revenue has surged by 170% since the previous quarter: https://fullratio.com/stocks/nasdaq-alvo/alvotech

FlynancialAnalyst Posted - 3 months ago

$ALVO $3.84B mc $XLV #HiddenGem (only 86 watchers on Stocktwits) rotating up off key $10 level on significant volume this week. Working on a rising 40 wk SMA remount FOUNDER LED, majority insider owned, 63.91% of shares outstanding Luxemburg-based Pct of all funds long shares at record highs & rising TrendEdge.app/asset/ALVO

pcguy2 Posted - 3 months ago

$ALVO "over 1 billion in milestone revenues remaining" earnings call

Bornjever Posted - 3 months ago

$ALVO this company now has 9 bio equals they are fully developed or in late stage development and big support from funds and big money with in excess of 2 billion invested and in quarter 4 of 2022 they lost 1.60 per share and now a profit of .28 and Humira equal just started to sell.

beatletull Posted - 3 months ago

@bginvest I'm looking at a stock here. Check out the news on Finviz.com - $ALVO. I'm considering buying it. The earnings is crazy, but the volume on this is only 311,771. What is your take on it? Conference call tomorrow morning also.

killasimba Posted - 3 months ago

$ALVO why is it down

pcguy2 Posted - 3 months ago

$ALVO 👍 👍 Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66 million, a 190% increase from the same period last year, with Q2 product revenues contributing $53 million

Stockhausen_ Posted - 3 months ago

$ALVO

Stock_Titan Posted - 3 months ago

$ALVO Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024 https://www.stocktitan.net/news/ALVO/alvotech-reports-record-revenues-and-adjusted-ebitda-for-the-second-ixpmh50hekth.html

Stock_Titan Posted - 3 months ago

$ALVO European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) https://www.stocktitan.net/news/ALVO/european-medicines-agency-confirms-acceptance-of-marketing-iywg5hcswsgp.html

Bornjever Posted - 3 months ago

$ALVO so sales last year were almost 100 million and this year projects over 400 million with bio equals like HUMIRA in play and many more and large investors have invested billions into this company. May have to wait till next quarter for much bigger revenue increase but this is a hold for gold

Stock_Titan Posted - 3 months ago

$ALVO Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET https://www.stocktitan.net/news/ALVO/alvotech-to-report-financial-results-for-the-first-half-of-2024-on-0hmtoo90mshu.html

Bornjever Posted - 07/29/24

$ALVO Big European investment in this company of billions and may have to cut price on some bio equals to gain market share as Humira equal now selling but need to be more aggressive and investors being patient because products and market is there only matter of time

DonCorleone77 Posted - 07/25/24

$ALVO Alvotech price target lowered to $18 from $22 at Barclays Barclays lowered the firm's price target on Alvotech to $18 from $22 and keeps an Overweight rating on the shares as part of a Q2 preview for the specialty pharmaceutical space. The analyst expects Q2 to provide continuing evidence that generics and biosimilars "are in the pink of health."

PenkeTrading Posted - 07/24/24

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Alvotech. Is that bullish or bearish? $ALVO #ALVO #nasdaq #tradingsignals #technicalanalysis

Stock_Titan Posted - 4 months ago

$ALVO STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe https://www.stocktitan.net/news/ALVO/stada-and-alvotech-launch-uzpruvo-the-first-approved-ustekinumab-uit0rn7b5ksz.html

Bornjever Posted - 4 months ago

$ALVO Xgeva is correct name

Bornjever Posted - 4 months ago

$ALVO we now have stage 3 passed in FDA equal to Prolia and Geva and August 27 will give us the first sales of Humira equal sales worldwide as this multi billion dollar in big boys financing is way undervalued and due to bust out.